Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T14:17:05.868Z.
Calculation as of: 2026-10-06T14:17:05.868Z.
Quote observation: 2026-10-06T14:15:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e4c5e5530b5f4ff9b2ae64c4564a307684e7c74323ce66c5db527ab157f5d0a0
PE RATIO
N/A
IceCure Medical Ltd
Market Cap
$3.33M
PE Ratio
N/A
| NAME | MARKET CAP | PE RATIO |
|---|---|---|
| IceCure Medical Ltd (ICCM) | $3.33M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.39M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.38M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.52M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.54M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.56M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.17M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.11M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$1.48
Forward EPS (Est.)
$-5.35
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
